MWA
HCA icon

Marshall Wace Asia’s HCA Healthcare HCA Stock Holding History

Marshall Wace Asia’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,969
Closed -$2.08M – 122
2019
Q1 		$2.08M Buy
+15,969
New +$2.14M 0.06% 76

Other funds holding HCA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Marshall Wace Asia's HCA Position: Q2 2019 in Review

Marshall Wace Asia sold out of HCA Healthcare (HCA) in Q2 2019, closing a stake of 15,969 shares — an estimated $2.08M sold.

Marshall Wace Asia first reported a position in HCA in Q1 2019 and held it in 1 quarter. The position peaked at $2.08M in Q1 2019. 675 funds tracked by Wall St. Rank hold HCA as of Q2 2019.

  • Marshall Wace Asia reported no remaining HCA Healthcare position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace Asia sold 15,969 HCA Healthcare shares in Q2 2019, an estimated $2.08M.
  • Marshall Wace Asia first reported a position in HCA Healthcare in Q1 2019 and held it in 1 quarter.
  • Marshall Wace Asia's HCA Healthcare position peaked at $2.08M in Q1 2019.
  • 675 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2019.

Based on Marshall Wace Asia's 13F filing for Q2 2019, filed 14 Aug 2019.